ARCHIVES

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

This article is from The Cancer Letter archive.

Vol. 20 No. 39 | October 14, 1994

Download PDF Visit The Full Archive

Related Articles

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

Latest U.S. cancer statistics cover 84% of population.

December 5, 2003

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

Home Test Detects Hematuria Earlier

August 4, 1989